Exporting Healthcare Equipment & Pharmaceuticals to Chile

Chile represents one of Latin America's most stable and attractive markets for US healthcare equipment and pharmaceutical exports. With a highly privatized healthcare system, strong regulatory alignment with international standards, and a growing aging population, the country offers consistent demand for advanced medical devices, diagnostics, and pharmaceutical products. For US exporters, Chile provides a transparent regulatory environment, low tariffs under the US-Chile Free Trade Agreement, and a sophisticated distribution network.

Local Market Size and Demand for Healthcare Equipment & Pharmaceuticals

Chile's healthcare expenditure reached approximately 9.2% of GDP in 2022, one of the highest ratios in Latin America (World Bank, 2023). The medical device market in Chile was valued at around $1.2 billion in 2023, with annual growth rates of 5–7% driven by investments in hospital infrastructure and the adoption of digital health technologies (GlobalData, 2024). The pharmaceutical market, meanwhile, was estimated at $3.5 billion in 2023, with generics accounting for nearly 60% of volume but branded products dominating value (IQVIA, 2024). Chile's population of 19.5 million is rapidly aging—over 14% are aged 65 or older—fueling demand for cardiovascular, orthopedic, and oncology products. The country also faces a rising burden of non-communicable diseases such as diabetes and hypertension, creating sustained need for chronic care pharmaceuticals and monitoring equipment.

Import Process: How Healthcare Products Enter Chile

Chile's import regime for healthcare equipment and pharmaceuticals is governed by two key agencies: the Instituto de Salud Pública (ISP) for pharmaceuticals and medical devices, and the Agencia Nacional de Medicamentos (ANAMED) for certain product registrations. Medical devices are classified into four risk classes (I to IV), with Class I devices requiring only notification and Class III/IV devices requiring full registration, including technical files and clinical evidence. The average registration timeline for Class II devices is 6–9 months, while Class III/IV can take 12–18 months. Pharmaceuticals require sanitary registration with the ISP, which involves submitting bioequivalence studies for generics and clinical trial data for new drugs. Under the US-Chile Free Trade Agreement, most medical devices and pharmaceuticals enter Chile duty-free, though a 19% value-added tax (IVA) applies at the point of importation. Importers must also comply with Chilean labeling requirements, which mandate Spanish-language instructions and specific warnings. The country uses the Harmonized System (HS) codes: 9018 for medical instruments, 3002 for human blood and vaccines, and 3004 for medicaments in dosage form.

Key Buyers and Distributors in Chile

The Chilean healthcare procurement landscape is divided between public and private sectors. The public sector, led by the Central de Abastecimiento del Sistema Nacional de Servicios de Salud (CENABAST), purchases approximately 40% of medical devices and pharmaceuticals through centralized tenders. The private sector, which accounts for the remaining 60%, is dominated by major hospital networks such as Clínica Alemana, Clínica Las Condes, and Red de Salud UC CHRISTUS. For pharmaceuticals, key distributors include Droguerías Cruz Verde, Droguería Salcobrand, and Farmacias Ahumada, which together control over 80% of retail pharmacy sales. Medical device distributors such as B. Braun Medical Chile, Johnson & Johnson Chile, and local firms like Tecnoimagen and Medtronic Chile serve as primary importers and after-sales service providers. US exporters typically partner with these established distributors to navigate regulatory approvals and access hospital procurement systems.

US Supplier Advantages for Healthcare Equipment & Pharmaceuticals in Chile

US manufacturers benefit from a strong reputation for quality and innovation among Chilean healthcare professionals. The US-Chile Free Trade Agreement eliminates tariffs on virtually all medical devices and pharmaceuticals, giving US products a cost advantage over competitors from non-FTA countries like China or India. Additionally, US regulatory approvals from the FDA are often accepted by the ISP as part of the registration process, reducing duplication of clinical evidence requirements. The Chilean peso's relative stability and the country's strong intellectual property protections—including data exclusivity periods for biologics—provide a secure environment for US exporters. US companies also enjoy access to financing through the Export-Import Bank of the United States and the U.S. Trade and Development Agency, which support healthcare infrastructure projects in Chile.

Coppermont Advisory

Coppermont provides end-to-end advisory services for US healthcare and pharmaceutical companies entering the Chilean market. We assist with regulatory strategy, including ISP registration and classification, distributor due diligence, and tender preparation for CENABAST bids. Our team of trade compliance experts ensures your products meet Chilean labeling, packaging, and quality standards. We also offer logistics coordination for temperature-sensitive pharmaceuticals and high-value medical equipment. Whether you are a small device manufacturer or a large pharmaceutical exporter, Coppermont can help you navigate Chile's regulatory landscape, identify qualified buyers, and structure your market entry for success. Contact us to schedule a consultation and learn how we can accelerate your exports to Chile.